{
    "text_blocks": {
        "data": {
            "block_count": 3,
            "table_index": 0
        },
        "model": {
            "gpt-4o-mini-2024-07-18": {
                "votes": {
                    "0": "0",
                    "1": "0",
                    "2": "0"
                },
                "decision": "0"
            },
            "gpt-4o-2024-08-06": {
                "votes": null,
                "decision": null
            }
        },
        "timestamp": "2025-01-21_09-32-20"
    },
    "table_comments": {
        "data": "CONSOLIDATED BALANCE SHEETS\t(In millions, except shares in thousands and per share data in dollars)\tDecember 31, 2022\tDecember 31, 2021\t",
        "timestamp": "2025-03-11_12-15-43"
    },
    "units": {
        "data": {
            "sum_units": 1000000,
            "sum_divider": 1.0
        },
        "model": {
            "gpt-4o-mini-2024-07-18": {
                "votes": {
                    "0": "1000000",
                    "1": "1000000"
                },
                "decision": "1000000"
            },
            "gpt-4o-2024-08-06": {
                "votes": null,
                "decision": null
            }
        },
        "timestamp": "2025-03-11_12-15-46"
    },
    "post_table_text": {
        "data": "\tThe accompanying notes to the consolidated financial statements are an integral part of these statements.\t61",
        "model": {
            "gpt-4o-mini-2024-07-18": {
                "trials": {
                    "0": "'\tThe accompanying notes to the consolidated financial statements are an integral part of these statements.\t61'"
                },
                "decision": "'\tThe accompanying notes to the consolidated financial statements are an integral part of these statements.\t61'"
            },
            "gpt-4o-2024-08-06": {
                "trials": {},
                "decision": null
            }
        },
        "timestamp": "2025-03-11_12-15-48"
    },
    "table_body": {
        "data": "ASSETS\tCurrent assets:\tCash and cash equivalents\t$\t12,074\t$\t13,118\tPremium and trade receivables\t13,272\t12,238\tShort-term investments\t2,321\t1,539\tOther current assets\t2,461\t1,602\tTotal current assets\t30,128\t28,497\tLong-term investments\t14,684\t14,043\tRestricted deposits\t1,217\t1,068\tProperty, software and equipment, net\t2,432\t3,391\tGoodwill\t18,812\t19,771\tIntangible assets, net\t6,911\t7,824\tOther long-term assets\t2,686\t3,781\tTotal assets\t$\t76,870\t$\t78,375\tLIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY\tCurrent liabilities:\tMedical claims liability\t$\t16,745\t$\t14,243\tAccounts payable and accrued expenses\t9,525\t8,493\tReturn of premium payable\t1,634\t2,328\tUnearned revenue\t478\t434\tCurrent portion of long-term debt\t82\t267\tTotal current liabilities\t28,464\t25,765\tLong-term debt\t17,938\t18,571\tDeferred tax liability\t615\t1,407\tOther long-term liabilities\t5,616\t5,610\tTotal liabilities\t52,633\t51,353\tCommitments and contingencies\tRedeemable noncontrolling interests\t56\t82\tStockholders' equity:\tPreferred stock, $\t0.001\tpar value; authorized\t10,000\tshares;\tno\tshares issued or outstanding at December 31, 2022 and December 31, 2021\t \t \tCommon stock, $\t0.001\tpar value; authorized\t800,000\tshares;\t607,847\tissued and\t550,754\toutstanding at December 31, 2022, and\t602,704\tissued and\t582,479\toutstanding at December 31, 2021\t1\t1\tAdditional paid-in capital\t20,060\t19,672\tAccumulated other comprehensive earnings (loss)\t(\t1,132\t)\t77\tRetained earnings\t9,341\t8,139\tTreasury stock, at cost (\t57,093\tand\t20,225\tshares, respectively)\t(\t4,213\t)\t(\t1,094\t)\tTotal Centene stockholders' equity\t24,057\t26,795\tNonredeemable noncontrolling interest\t124\t145\tTotal stockholders' equity\t24,181\t26,940\tTotal liabilities, redeemable noncontrolling interests and stockholders' equity\t$\t76,870\t$\t78,375",
        "timestamp": "2025-03-11_12-15-48"
    },
    "table_json_created": {
        "data": true,
        "model": {
            "gpt-4o-mini-2024-07-18": {
                "trials": {
                    "0": "{\"ASSETS\": {\"Current assets\": {\"Cash and cash equivalents\": [12074, 13118], \"Premium and trade receivables\": [13272, 12238], \"Short-term investments\": [2321, 1539], \"Other current assets\": [2461, 1602], \"Total current assets\": [30128, 28497]}, \"Long-term investments\": [14684, 14043], \"Restricted deposits\": [1217, 1068], \"Property, software and equipment, net\": [2432, 3391], \"Goodwill\": [18812, 19771], \"Intangible assets, net\": [6911, 7824], \"Other long-term assets\": [2686, 3781], \"Total assets\": [76870, 78375]}, \"LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY\": {\"Current liabilities\": {\"Medical claims liability\": [16745, 14243], \"Accounts payable and accrued expenses\": [9525, 8493], \"Return of premium payable\": [1634, 2328], \"Unearned revenue\": [478, 434], \"Current portion of long-term debt\": [82, 267], \"Total current liabilities\": [28464, 25765]}, \"Long-term debt\": [17938, 18571], \"Deferred tax liability\": [615, 1407], \"Other long-term liabilities\": [5616, 5610], \"Total liabilities\": [52633, 51353], \"Commitments and contingencies\": null, \"Redeemable noncontrolling interests\": [56, 82], \"Stockholders' equity\": {\"Preferred stock, $ 0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December 31, 2022 and December 31, 2021\": [0, 0], \"Common stock, $ 0.001 par value; authorized 800,000 shares; 607,847 issued and 550,754 outstanding at December 31, 2022, and 602,704 issued and 582,479 outstanding at December 31, 2021\": [1, 1], \"Additional paid-in capital\": [20060, 19672], \"Accumulated other comprehensive earnings (loss)\": [-1132, 77], \"Retained earnings\": [9341, 8139], \"Treasury stock, at cost ( 57,093 and 20,225 shares, respectively)\": [-4213, -1094], \"Total Centene stockholders' equity\": [24057, 26795], \"Nonredeemable noncontrolling interest\": [124, 145], \"Total stockholders' equity\": [24181, 26940]}, \"Total liabilities, redeemable noncontrolling interests and stockholders' equity\": [76870, 78375]}}"
                },
                "decision": "{\"ASSETS\": {\"Current assets\": {\"Cash and cash equivalents\": [12074, 13118], \"Premium and trade receivables\": [13272, 12238], \"Short-term investments\": [2321, 1539], \"Other current assets\": [2461, 1602], \"Total current assets\": [30128, 28497]}, \"Long-term investments\": [14684, 14043], \"Restricted deposits\": [1217, 1068], \"Property, software and equipment, net\": [2432, 3391], \"Goodwill\": [18812, 19771], \"Intangible assets, net\": [6911, 7824], \"Other long-term assets\": [2686, 3781], \"Total assets\": [76870, 78375]}, \"LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY\": {\"Current liabilities\": {\"Medical claims liability\": [16745, 14243], \"Accounts payable and accrued expenses\": [9525, 8493], \"Return of premium payable\": [1634, 2328], \"Unearned revenue\": [478, 434], \"Current portion of long-term debt\": [82, 267], \"Total current liabilities\": [28464, 25765]}, \"Long-term debt\": [17938, 18571], \"Deferred tax liability\": [615, 1407], \"Other long-term liabilities\": [5616, 5610], \"Total liabilities\": [52633, 51353], \"Commitments and contingencies\": null, \"Redeemable noncontrolling interests\": [56, 82], \"Stockholders' equity\": {\"Preferred stock, $ 0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December 31, 2022 and December 31, 2021\": [0, 0], \"Common stock, $ 0.001 par value; authorized 800,000 shares; 607,847 issued and 550,754 outstanding at December 31, 2022, and 602,704 issued and 582,479 outstanding at December 31, 2021\": [1, 1], \"Additional paid-in capital\": [20060, 19672], \"Accumulated other comprehensive earnings (loss)\": [-1132, 77], \"Retained earnings\": [9341, 8139], \"Treasury stock, at cost ( 57,093 and 20,225 shares, respectively)\": [-4213, -1094], \"Total Centene stockholders' equity\": [24057, 26795], \"Nonredeemable noncontrolling interest\": [124, 145], \"Total stockholders' equity\": [24181, 26940]}, \"Total liabilities, redeemable noncontrolling interests and stockholders' equity\": [76870, 78375]}}"
            },
            "gpt-4o-2024-08-06": {
                "trials": {},
                "decision": null
            }
        },
        "timestamp": "2025-03-12_11-22-29"
    },
    "problems": {
        "data": [],
        "timestamp": "2025-03-12_11-22-29"
    }
}